المؤلفون: Ettore Capoluongo, Sandro Pignata, Paola Carrera, Enrico Ricevuto, Maurizio Genuardi, Paolo Radice, Antonio Russo, Nicoletta Colombo, Carmine Pinto, Stefania Gori, Barbara Pasini, Paolo Marchetti, Nicola Normanno, Valentina Guarneri, Laura Cortesi, Antonio Marchetti, Mauro Truini, Maria Angela Bella, Pierosandro Tagliaferri, Pierfrancesco Tassone, Gaetano De Rosa, Francesca Fenizia, Claudio Clemente, Liliana Varesco

المساهمون: Pinto, Carmine, Bella, Maria Angela, Capoluongo, Ettore, Carrera, Paola, Clemente, Claudio, Colombo, Nicoletta, Cortesi, Laura, DE ROSA, Gaetano, Fenizia, Francesca, Genuardi, Maurizio, Gori, Stefania, Guarneri, Valentina, Marchetti, Antonio, Marchetti, Paolo, Normanno, Nicola, Pasini, Barbara, Pignata, Sandro, Radice, Paolo, Ricevuto, Enrico, Russo, Antonio, Tagliaferri, Pierosandro, Tassone, Pierfrancesco, Truini, Mauro, Varesco, Liliana, Pinto, C., Bella, M., Capoluongo, E., Carrera, P., Clemente, C., Colombo, N., Cortesi, L., De Rosa, G., Fenizia, F., Genuardi, M., Gori, S., Guarneri, V., Marchetti, A., Marchetti, P., Normanno, N., Pasini, B., Pignata, S., Radice, P., Ricevuto, E., Russo, A., Tagliaferri, P., Tassone, P., Truini, M., Varesco, L., Pinto, C, Bella, M, Capoluongo, E, Carrera, P, Clemente, C, Colombo, N, Cortesi, L, De Rosa, G, Fenizia, F, Genuardi, M, Gori, S, Guarneri, V, Marchetti, A, Marchetti, P, Normanno, N, Pasini, B, Pignata, S, Radice, P, Ricevuto, E, Russo, A, Tagliaferri, P, Tassone, P, Truini, M, Varesco, L

مصطلحات موضوعية: 0301 basic medicine, Oncology, Cancer Research, Genes, BRCA2, Genes, BRCA1, Brca testing, BRCA1, BRCA2, genetic testing, germline mutations, ovarian cancer, PARP inhibitors, somatic mutations, Settore MED/03 - GENETICA MEDICA, 0302 clinical medicine, Clinical decision making, Informed consent, somatic mutation, BRCA1, BRCA2, genetic testing, germline mutations, somatic mutations, ovarian cancer, PARP inibitors, Disease management (health), Ovarian Neoplasms, Tumor, Informed Consent, medicine.diagnostic_test, Disease Management, General Medicine, Prognosis, Biomarkers, Tumor, Clinical Decision-Making, Female, Genetic Variation, Germ-Line Mutation, Humans, Mutation, Genetic Testing, germline mutation, 030220 oncology & carcinogenesis, Human, medicine.medical_specialty, Prognosi, MEDLINE, 03 medical and health sciences, PARP inibitors, Internal medicine, medicine, Genetic testing, Gynecology, business.industry, Ovarian Neoplasm, medicine.disease, 030104 developmental biology, PARP inhibitor, Genes, Ovarian cancer, business, Biomarkers

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5eb9b4ad22ad35cde975131fad7a5a30
http://hdl.handle.net/11577/3362422